AI + Digital Maturity in Contract Manufacturing
Exclusive Report

External Manufacturing Leaders Boston

CDMO Live Americas 2026 Early Bird

Agenda Download

Days

Hours

Minutes

Seconds

CDMO News

Nanoform Signs U.S. Pharma Partnership for Biologics Technology

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Lonza Launches Xcite AAV Stable Producer Cell Line Platform

Trisk Bio Partners with NanoMosaic on AAV Analytics Platform

Cellares Partners with ProTgen on Automated T Cell Therapy Manufacturing

Hovione Appoints Interim Co-CEOs Following CEO Transition

More CDMO News

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Lonza Launches Xcite AAV Stable Producer Cell Line Platform

Trisk Bio Partners with NanoMosaic on AAV Analytics Platform

Cellares Partners with ProTgen on Automated T Cell Therapy Manufacturing

Hovione Appoints Interim Co-CEOs Following CEO Transition

More CDMO News

White Paper[Download]

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

CDMO News

CDMO News

Nanoform Signs U.S. Pharma Partnership for Biologics Technology

Nanoform Signs U.S. Pharma Partnership for Biologics Technology

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Lonza Launches Xcite AAV Stable Producer Cell Line Platform

Trisk Bio Partners with NanoMosaic on AAV Analytics Platform

Cellares Partners with ProTgen on Automated T Cell Therapy Manufacturing

Hovione Appoints Interim Co-CEOs Following CEO Transition

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Lonza Launches Xcite AAV Stable Producer Cell Line Platform

Trisk Bio Partners with NanoMosaic on AAV Analytics Platform

Cellares Partners with ProTgen on Automated T Cell Therapy Manufacturing

Hovione Appoints Interim Co-CEOs Following CEO Transition

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Drug Development Readiness: Interactive Checklist and RACI

Welcome to PharmaSource

Follow us

Top Links

Get in touch